Supernus Pharmaceuticals, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income 0.61M77.04M-46.28M-92.27M-10.93M13.94M91.22M57.28M110.99M113.06M126.95M53.42M60.71M1.32M73.86M
Depreciation and Depletion 0.96M0.65M0.64M0.51M0.70M
Share-based Compensation 0.30M-0.08M0.44M1.91M2.86M4.09M5.93M8.43M11.29M14.85M16.56M17.91M17.57M26.76M27.75M
Deferred Taxes 18.75M31.53M-41.79M21.22M-4.17M-5.83M0.57M-4.99M-26.32M-25.71M-20.14M
Cash from Discontinued Operations -0.35M2.02M
Gains from Investment Securities 0.05M-2.15M0.57M1.46M2.08M2.70M3.64M1.59M34.77M51.54M45.43M25.19M16.20M36.60M53.25M
Asset Writedowns and Impairment 10.44M20.19M8.90M
Non-cash Items 0.59M1.90M0.20M1.40M0.63M0.90M1.50M108.52M57.22M
Cash from Operations -32.54M-38.21M-47.20M-57.95M-24.50M34.52M66.81M114.64M128.99M143.13M138.40M127.13M116.83M111.08M171.95M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.06M-0.24M0.56M1.67M4.03M2.89M-0.42M-3.23M0.12M-1.82M
Amortization of Deferred Charges 0.22M0.33M3.03M2.09M0.69M0.28M0.05M11.85M15.71M16.60M17.50M2.11M0.53M
Depreciation & Amortization (CF) 1.19M0.88M0.87M0.74M0.93M0.92M2.40M8.13M7.06M6.66M18.14M32.59M85.54M84.86M80.41M
Change in Working Capital
Change in Receivables -0.28M-0.04M0.01M5.04M12.22M8.64M15.62M24.06M35.86M-15.75M34.61M-3.87M16.37M-18.77M-2.08M
Change in Inventory 1.15M6.00M6.29M-0.85M4.21M-0.50M9.36M0.97M10.12M14.58M17.86M-6.11M-15.81M
Change in Account Payables 0.32M0.34M-2.05M2.06M3.47M-0.62M-3.58M6.96M
Change in Accured Expenses 5.21M-0.96M-1.42M7.16M2.03M0.51M7.54M26.40M38.72M-11.68M10.39M18.18M-19.16M-36.29M-15.02M
Change in Taxes 0.01M15.93M-3.56M-9.93M
Other Working Capital Changes -0.07M0.54M1.18M0.89M1.20M0.49M-0.33M6.51M0.83M-5.09M-12.30M0.33M19.35M
Investing Activities
Capital Expenditures 0.29M0.69M0.75M1.65M0.59M2.10M1.60M2.03M0.84M2.74M3.45M0.41M0.55M0.72M
Change in Intangibles 0.70M2.28M10.91M18.82M11.15M0.81M1.35M
Acquisitions 15.00M298.54M0.95M
Divestments 25.61M
Change in Acquisitions & Divestments 58.90M26.87M49.47M75.81M53.47M37.58M31.82M28.66M79.83M253.17M378.42M530.51M190.74M370.90M498.87M
Cash from Investing Activities 25.82M33.90M-48.96M-12.11M-2.66M-39.29M-35.96M-86.42M-413.48M-157.92M-34.70M-81.91M-216.66M268.73M-189.87M
Financing Activities
Other financing activities 1.34M-1.97M6.04M3.63M
Cash from Financing Activities -1.34M29.05M87.92M62.74M30.57M1.87M2.05M5.68M376.44M3.93M3.56M-130.42M-10.48M-397.88M12.19M
Additional items
Change in Cash -7.67M24.80M-8.24M-7.32M3.42M-2.90M32.90M33.91M91.94M-10.87M107.26M-85.21M-110.31M-18.07M-5.72M
Beginning Cash Balance 31.41M23.74M48.54M40.30M32.98M36.40M33.50M66.40M100.30M192.25M181.38M288.64M203.43M93.12M75.05M
Free Cash Flow -32.84M-38.89M-47.95M-59.59M-25.09M32.42M65.21M112.61M128.14M140.39M134.95M127.13M116.41M110.53M171.23M
Net Cash Flow -8.06M24.75M-8.24M-7.32M3.42M-2.90M32.90M33.91M91.94M-10.87M107.26M-85.21M-110.31M-18.07M-5.72M